Drug Information

Drug General Information
Drug ID
D09DSZ
Former ID
DNC010107
Drug Name
2,3-dihydrobenzo[d]thiazole-2-thiol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530623]
Formula
C7H7NS2
Canonical SMILES
C1=CC=C2C(=C1)NC(S2)S
InChI
1S/C7H7NS2/c9-7-8-5-3-1-2-4-6(5)10-7/h1-4,7-9H
InChIKey
PYVUUPVBIDIYPY-UHFFFAOYSA-N
PubChem Compound ID
3266369
Target and Pathway
Target(s) Indoleamine 2,3-dioxygenase Target Info Inhibitor [530623]
BioCyc Pathway Superpathway of tryptophan utilization
Tryptophan degradation
L-kynurenine degradation
Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
NAD de novo biosynthesis
KEGG Pathway Tryptophan metabolism
Metabolic pathways
African trypanosomiasis
NetPath Pathway TSLP Signaling Pathway
IL5 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
PathWhiz Pathway Tryptophan Metabolism
Reactome Tryptophan catabolism
WikiPathways Tryptophan metabolism
Metabolism of amino acids and derivatives
References
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.
Ref 530623J Med Chem. 2010 Feb 11;53(3):1172-89.Rational design of indoleamine 2,3-dioxygenase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.